Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis

S Gordon, 2003, Alternative activation of macrophages., Nat Rev Immunol, 3, 23, 10.1038/nri978

TA Wynn, 2004, Fibrotic disease and the T(H)1/T(H)2 paradigm., Nat Rev Immunol, 4, 583, 10.1038/nri1412

M Munder, 1998, Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype., J Immunol, 160, 5347, 10.4049/jimmunol.160.11.5347

AL Pauleau, 2004, Enhancer-mediated control of macrophage-specific arginase I expression., J Immunol, 172, 7565, 10.4049/jimmunol.172.12.7565

T Gotoh, 1996, Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line., FEBS Lett, 395, 119, 10.1016/0014-5793(96)01015-0

SM Morris Jr, 2007, Arginine metabolism: boundaries of our knowledge., J Nutr, 137, 1602S, 10.1093/jn/137.6.1602S

HD Brightbill, 1999, Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors., Science, 285, 732, 10.1126/science.285.5428.732

KC El Kasmi, 2008, Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens., Nat Immunol, 9, 1399, 10.1038/ni.1671

EJ Pearce, 2002, The immunobiology of schistosomiasis., Nat Rev Immunol, 2, 499, 10.1038/nri843

J Pesce, 2006, The IL-21 receptor augments Th2 effector function and alternative macrophage activation., J Clin Invest, 116, 2044, 10.1172/JCI27727

M Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism., J Immunol, 167, 6533, 10.4049/jimmunol.167.11.6533

P Loke, 2007, Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection., J Immunol, 179, 3926, 10.4049/jimmunol.179.6.3926

RM Anthony, 2006, Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites., Nat Med, 12, 955, 10.1038/nm1451

M Yang, 2006, Inhibition of arginase I activity by RNA interference attenuates IL-13–induced airways hyperresponsiveness., J Immunol, 177, 5595, 10.4049/jimmunol.177.8.5595

A Zhao, 2008, Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages., Gastroenterology, 135, 217, 10.1053/j.gastro.2008.03.077

BE Clausen, 1999, Conditional gene targeting in macrophages and granulocytes using LysMcre mice., Transgenic Res, 8, 265, 10.1023/A:1008942828960

N Faust, 2000, Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages., Blood, 96, 719, 10.1182/blood.V96.2.719

M Ye, 2003, Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential., Immunity, 19, 689, 10.1016/S1074-7613(03)00299-1

TA Reese, 2007, Chitin induces accumulation in tissue of innate immune cells associated with allergy., Nature, 447, 92, 10.1038/nature05746

TA Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases., J Clin Invest, 117, 524, 10.1172/JCI31487

MD Taylor, 2006, F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection., J Immunol, 176, 6918, 10.4049/jimmunol.176.11.6918

LR Brunet, 1997, IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis., J Immunol, 159, 777, 10.4049/jimmunol.159.2.777

DR Herbert, 2004, Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology., Immunity, 20, 623, 10.1016/S1074-7613(04)00107-4

V Bronte, 2005, Regulation of immune responses by L-arginine metabolism., Nat Rev Immunol, 5, 641, 10.1038/nri1668

M Modolell, 1995, Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines., Eur J Immunol, 25, 1101, 10.1002/eji.1830250436

AS MacFarlane, 1999, In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen., Infect Immun, 67, 891, 10.1128/IAI.67.2.891-898.1999

JL Flynn, 1998, Effects of aminoguanidine on latent murine tuberculosis., J Immunol, 160, 1796, 10.4049/jimmunol.160.4.1796

LR Brunet, 1999, Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection., J Immunol, 163, 4976, 10.4049/jimmunol.163.9.4976

D Jankovic, 1999, Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile., J Immunol, 163, 337, 10.4049/jimmunol.163.1.337

AK Abbas, 1996, Functional diversity of helper T lymphocytes., Nature, 383, 787, 10.1038/383787a0

PG Fallon, 2000, Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent., J Immunol, 164, 2585, 10.4049/jimmunol.164.5.2585

GJ McKenzie, 1999, Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses., J Exp Med, 189, 1565, 10.1084/jem.189.10.1565

AW Cheever, 2000, Immunopathology of schistosomiasis mansoni in mice and men., Immunol Today, 21, 465, 10.1016/S0167-5699(00)01626-1

KF Hoffmann, 2000, IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis., J Immunol, 164, 6406, 10.4049/jimmunol.164.12.6406

MG Chiaramonte, 1999, An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response., J Clin Invest, 104, 777, 10.1172/JCI7325

MG Chiaramonte, 2003, Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response., J Exp Med, 197, 687, 10.1084/jem.20020903

RM Reiman, 2006, Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity., Infect Immun, 74, 1471, 10.1128/IAI.74.3.1471-1479.2006

MG Chiaramonte, 2001, Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis., Hepatology, 34, 273, 10.1053/jhep.2001.26376

TR Ramalingam, 2008, Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain., Nat Immunol, 9, 25, 10.1038/ni1544

TA Wynn, 2003, IL-13 effector functions., Annu Rev Immunol, 21, 425, 10.1146/annurev.immunol.21.120601.141142

TA Wynn, 2004, Immunopathogenesis of schistosomiasis., Immunol Rev, 201, 156, 10.1111/j.0105-2896.2004.00176.x

Z Zhu, 2004, Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation., Science, 304, 1678, 10.1126/science.1095336

M Yang, 2006, Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness., J Immunol, 177, 5595, 10.4049/jimmunol.177.8.5595

V Bronte, 2003, IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice., J Immunol, 170, 270, 10.4049/jimmunol.170.1.270

V Bronte, 2003, L-arginine metabolism in myeloid cells controls T-lymphocyte functions., Trends Immunol, 24, 302, 10.1016/S1471-4906(03)00132-7

G Gallina, 2006, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells., J Clin Invest, 116, 2777, 10.1172/JCI28828

PC Rodriguez, 2004, Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses., Cancer Res, 64, 5839, 10.1158/0008-5472.CAN-04-0465

PC Rodriguez, 2002, Regulation of T cell receptor CD3zeta chain expression by L-arginine., J Biol Chem, 277, 21123, 10.1074/jbc.M110675200

AH Zea, 2005, Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion., Cancer Res, 65, 3044, 10.1158/0008-5472.CAN-04-4505

TM Doherty, 1993, Modulation of murine macrophage function by IL-13., J Immunol, 151, 7151, 10.4049/jimmunol.151.12.7151

S Goerdt, 1999, Alternative versus classical activation of macrophages., Pathobiology, 67, 222, 10.1159/000028096

N Hayashi, 1999, Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens., J Immunol, 163, 6702, 10.4049/jimmunol.163.12.6702

CD Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm., J Immunol, 164, 6166, 10.4049/jimmunol.164.12.6166

MJ Rauh, 2005, SHIP represses the generation of alternatively activated macrophages., Immunity, 23, 361, 10.1016/j.immuni.2005.09.003

LH Wei, 2000, IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells., Am J Physiol Cell Physiol, 279, C248, 10.1152/ajpcell.2000.279.1.C248

M Hesse, 2000, NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease., Am J Pathol, 157, 945, 10.1016/S0002-9440(10)64607-X